|
LTA4H expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.403200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.157460E-03 |
| Normal-vs-Stage2 |
2.962600E-01 |
| Normal-vs-Stage3 |
3.940500E-03 |
| Normal-vs-Stage4 |
3.706000E-02 |
| Stage1-vs-Stage2 |
4.779600E-01 |
| Stage1-vs-Stage3 |
9.124800E-01 |
| Stage1-vs-Stage4 |
9.739600E-01 |
| Stage2-vs-Stage3 |
4.632200E-01 |
| Stage2-vs-Stage4 |
5.617800E-01 |
| Stage3-vs-Stage4 |
9.138000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.611110E-04 |
| Normal-vs-AfricanAmerican |
1.097450E-03 |
| Normal-vs-Asian |
3.112200E-02 |
| Caucasian-vs-AfricanAmerican |
4.467200E-01 |
| Caucasian-vs-Asian |
6.904200E-01 |
| AfricanAmerican-vs-Asian |
3.002600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.044670E-03 |
| Normal-vs-Female |
2.856600E-03 |
| Male-vs-Female |
2.626400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.003600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.175830E-02 |
| Normal-vs-Age(61-80Yrs) |
2.994400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.890000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.358000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.775400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.225800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.748800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.656400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.754800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.980400E-01 |
| Classical-VS-Follicular |
1.92950000421632E-09 |
| Classical-VS-Other |
3.226800E-01 |
| Classical-VS-Normal |
2.18439999999376E-06 |
| Tall-VS-Follicular |
1.999500E-04 |
| Tall-VS-Other |
2.935600E-01 |
| Tall-VS-Normal |
1.716390E-03 |
| Follicular-VS-Other |
3.203600E-01 |
| Follicular-VS-Normal |
1.066180E-01 |
| Other-VS-Normal |
7.391400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.900300E-02 |
| Normal-vs-N1 |
2.577600E-01 |
| N0-vs-N1 |
9.400400E-01 |
|
|
